Airlines, Airports & Air Services
Compare Stocks
5 / 10Stock Comparison
SRTA vs SPIR vs ASTS vs ENSG vs GSAT
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
Communication Equipment
Medical - Care Facilities
Telecommunications Services
SRTA vs SPIR vs ASTS vs ENSG vs GSAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Airlines, Airports & Air Services | Specialty Business Services | Communication Equipment | Medical - Care Facilities | Telecommunications Services |
| Market Cap | $482M | $607.77B | $21.96B | $10.02B | $10.56B |
| Revenue (TTM) | $210M | $72M | $71M | $5.27B | $283M |
| Net Income (TTM) | $47M | $-25.02B | $-342M | $363M | $-14M |
| Gross Margin | 20.6% | 40.8% | 53.4% | 15.2% | 40.9% |
| Operating Margin | -8.4% | -121.4% | -405.7% | 8.5% | 8.6% |
| Forward P/E | 11.1x | 11.5x | — | 22.7x | — |
| Total Debt | $3M | $8.76B | $32M | $4.15B | $546M |
| Cash & Equiv. | $31M | $24.81B | $2.34B | $504M | $447M |
SRTA vs SPIR vs ASTS vs ENSG vs GSAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Strata Critical Med… (SRTA) | 100 | 55.9 | -44.1% |
| Spire Global, Inc. (SPIR) | 100 | 23.5 | -76.5% |
| AST SpaceMobile, In… (ASTS) | 100 | 741.2 | +641.2% |
| The Ensign Group, I… (ENSG) | 100 | 238.6 | +138.6% |
| Globalstar, Inc. (GSAT) | 100 | 1699.6 | +1599.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SRTA vs SPIR vs ASTS vs ENSG vs GSAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SRTA carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 2.47, Low D/E 1.2%, current ratio 6.38x
- Better valuation composite
- 22.4% margin vs SPIR's -349.6%
- 15.1% ROA vs SPIR's -47.3%, ROIC -7.2% vs -0.1%
Among these 5 stocks, SPIR doesn't own a clear edge in any measured category.
ASTS ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 15.1%, EPS growth 30.9%, 3Y rev CAGR 72.5%
- 6.7% 10Y total return vs ENSG's 7.4%
- 15.1% revenue growth vs SPIR's -35.2%
ENSG is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 12 yrs, beta 0.38, yield 0.1%
- Beta 0.38, yield 0.1%, current ratio 1.42x
- Beta 0.38 vs SPIR's 3.10
- 0.1% yield, 12-year raise streak, vs GSAT's 0.1%, (3 stocks pay no dividend)
GSAT is the clearest fit if your priority is momentum.
- +306.6% vs ENSG's +26.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.1% revenue growth vs SPIR's -35.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 22.4% margin vs SPIR's -349.6% | |
| Stability / Safety | Beta 0.38 vs SPIR's 3.10 | |
| Dividends | 0.1% yield, 12-year raise streak, vs GSAT's 0.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +306.6% vs ENSG's +26.0% | |
| Efficiency (ROA) | 15.1% ROA vs SPIR's -47.3%, ROIC -7.2% vs -0.1% |
SRTA vs SPIR vs ASTS vs ENSG vs GSAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SRTA vs SPIR vs ASTS vs ENSG vs GSAT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ENSG leads in 3 of 6 categories
ASTS leads 1 • SRTA leads 0 • SPIR leads 0 • GSAT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SRTA and ASTS and GSAT each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 74.4x ASTS's $71M. SRTA is the more profitable business, keeping 22.4% of every revenue dollar as net income compared to SPIR's -349.6%. On growth, ASTS holds the edge at +27.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $210M | $72M | $71M | $5.3B | $283M |
| EBITDAEarnings before interest/tax | -$11M | -$74M | -$237M | $558M | $108M |
| Net IncomeAfter-tax profit | $47M | -$25.0B | -$342M | $363M | -$14M |
| Free Cash FlowCash after capex | -$54M | -$16.2B | -$1.1B | $406M | $45M |
| Gross MarginGross profit ÷ Revenue | +20.6% | +40.8% | +53.4% | +15.2% | +40.9% |
| Operating MarginEBIT ÷ Revenue | -8.4% | -121.4% | -4.1% | +8.5% | +8.6% |
| Net MarginNet income ÷ Revenue | +22.4% | -349.6% | -4.8% | +6.9% | -5.0% |
| FCF MarginFCF ÷ Revenue | -25.7% | -227.0% | -16.0% | +7.7% | +15.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +24.1% | -26.9% | +27.3% | +18.4% | +16.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +175.0% | +59.5% | -55.6% | +21.9% | 0.0% |
Valuation Metrics
ENSG leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 11.1x trailing earnings, SRTA trades at a 62% valuation discount to ENSG's 29.4x P/E. On an enterprise value basis, ENSG's 25.4x EV/EBITDA is more attractive than GSAT's 104.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $482M | $607.8B | $22.0B | $10.0B | $10.6B |
| Enterprise ValueMkt cap + debt − cash | $454M | $591.7B | $19.7B | $13.7B | $10.7B |
| Trailing P/EPrice ÷ TTM EPS | 11.14x | 11.48x | -56.01x | 29.36x | -547.27x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 22.68x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.13x | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 25.40x | 104.40x |
| Price / SalesMarket cap ÷ Revenue | 2.44x | 8493.94x | 309.69x | 1.98x | 38.67x |
| Price / BookPrice ÷ Book value/share | 1.65x | 5.23x | 6.53x | 4.52x | 29.25x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 27.02x | 137.46x |
Profitability & Efficiency
ENSG leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SRTA delivers a 17.6% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-88 for SPIR. ASTS carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), SPIR scores 5/9 vs SRTA's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.6% | -88.4% | -21.1% | +16.6% | -3.9% |
| ROA (TTM)Return on assets | +15.1% | -47.3% | -12.6% | +6.8% | -0.6% |
| ROICReturn on invested capital | -7.2% | -0.1% | -47.1% | +7.0% | +2.3% |
| ROCEReturn on capital employed | -8.3% | -0.1% | -10.0% | +10.2% | +0.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 5 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.01x | 0.08x | 0.01x | 1.86x | 1.54x |
| Net DebtTotal debt minus cash | -$28M | -$16.1B | -$2.3B | $3.7B | $99M |
| Cash & Equiv.Liquid assets | $31M | $24.8B | $2.3B | $504M | $447M |
| Total DebtShort + long-term debt | $3M | $8.8B | $32M | $4.2B | $546M |
| Interest CoverageEBIT ÷ Interest expense | — | 9.20x | -21.20x | 88.33x | — |
Total Returns (Dividends Reinvested)
ASTS leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ASTS five years ago would be worth $97,215 today (with dividends reinvested), compared to $2,337 for SPIR. Over the past 12 months, GSAT leads with a +306.6% total return vs ENSG's +26.0%. The 3-year compound annual growth rate (CAGR) favors ASTS at 145.9% vs ENSG's 23.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +13.0% | +136.7% | -10.1% | -1.4% | +28.3% |
| 1-Year ReturnPast 12 months | +88.2% | +93.8% | +197.2% | +26.0% | +306.6% |
| 3-Year ReturnCumulative with dividends | +104.0% | +242.0% | +1386.1% | +85.9% | +488.5% |
| 5-Year ReturnCumulative with dividends | -27.8% | -76.6% | +872.1% | +105.6% | +402.1% |
| 10-Year ReturnCumulative with dividends | -42.9% | -75.7% | +668.2% | +738.2% | +204.0% |
| CAGR (3Y)Annualised 3-year return | +26.8% | +50.7% | +145.9% | +23.0% | +80.5% |
Risk & Volatility
Evenly matched — ENSG and GSAT each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than SPIR's 3.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GSAT currently trades 99.1% from its 52-week high vs ASTS's 57.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.47x | 3.10x | 2.83x | 0.38x | 2.04x |
| 52-Week HighHighest price in past year | $6.02 | $23.59 | $129.89 | $218.00 | $82.85 |
| 52-Week LowLowest price in past year | $2.84 | $6.60 | $22.47 | $134.68 | $17.24 |
| % of 52W HighCurrent price vs 52-week peak | +92.5% | +78.4% | +57.8% | +78.6% | +99.1% |
| RSI (14)Momentum oscillator 0–100 | 66.1 | 47.7 | 38.1 | 22.0 | 64.2 |
| Avg Volume (50D)Average daily shares traded | 787K | 1.6M | 15.1M | 364K | 1.5M |
Analyst Outlook
ENSG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SRTA as "Buy", SPIR as "Buy", ASTS as "Buy", ENSG as "Buy", GSAT as "Hold". Consensus price targets imply 38.1% upside for ASTS (target: $104) vs -19.6% for GSAT (target: $66). For income investors, ENSG offers the higher dividend yield at 0.14% vs GSAT's 0.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $7.25 | $17.25 | $103.65 | $222.33 | $66.00 |
| # AnalystsCovering analysts | 6 | 12 | 7 | 13 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.1% | +0.1% |
| Dividend StreakConsecutive years of raises | — | — | — | 12 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $0.24 | $0.08 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.2% | 0.0% |
ENSG leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). ASTS leads in 1 (Total Returns). 2 tied.
SRTA vs SPIR vs ASTS vs ENSG vs GSAT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SRTA or SPIR or ASTS or ENSG or GSAT a better buy right now?
For growth investors, AST SpaceMobile, Inc.
(ASTS) is the stronger pick with 1505% revenue growth year-over-year, versus -35. 2% for Spire Global, Inc. (SPIR). Strata Critical Medical, Inc. (SRTA) offers the better valuation at 11. 1x trailing P/E, making it the more compelling value choice. Analysts rate Strata Critical Medical, Inc. (SRTA) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SRTA or SPIR or ASTS or ENSG or GSAT?
On trailing P/E, Strata Critical Medical, Inc.
(SRTA) is the cheapest at 11. 1x versus The Ensign Group, Inc. at 29. 4x.
03Which is the better long-term investment — SRTA or SPIR or ASTS or ENSG or GSAT?
Over the past 5 years, AST SpaceMobile, Inc.
(ASTS) delivered a total return of +872. 1%, compared to -76. 6% for Spire Global, Inc. (SPIR). Over 10 years, the gap is even starker: ENSG returned +738. 2% versus SPIR's -75. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SRTA or SPIR or ASTS or ENSG or GSAT?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 38β versus Spire Global, Inc. 's 3. 10β — meaning SPIR is approximately 718% more volatile than ENSG relative to the S&P 500. On balance sheet safety, AST SpaceMobile, Inc. (ASTS) carries a lower debt/equity ratio of 1% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SRTA or SPIR or ASTS or ENSG or GSAT?
By revenue growth (latest reported year), AST SpaceMobile, Inc.
(ASTS) is pulling ahead at 1505% versus -35. 2% for Spire Global, Inc. (SPIR). On earnings-per-share growth, the picture is similar: Strata Critical Medical, Inc. grew EPS 242. 9% year-over-year, compared to 14. 1% for The Ensign Group, Inc.. Over a 3-year CAGR, ASTS leads at 72. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SRTA or SPIR or ASTS or ENSG or GSAT?
Spire Global, Inc.
(SPIR) is the more profitable company, earning 71. 7% net margin versus -482. 2% for AST SpaceMobile, Inc. — meaning it keeps 71. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ENSG leads at 8. 6% versus -405. 7% for ASTS. At the gross margin level — before operating expenses — GSAT leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SRTA or SPIR or ASTS or ENSG or GSAT more undervalued right now?
Analyst consensus price targets imply the most upside for ASTS: 38.
1% to $103. 65.
08Which pays a better dividend — SRTA or SPIR or ASTS or ENSG or GSAT?
In this comparison, ENSG (0.
1% yield), GSAT (0. 1% yield) pay a dividend. SRTA, SPIR, ASTS do not pay a meaningful dividend and should not be held primarily for income.
09Is SRTA or SPIR or ASTS or ENSG or GSAT better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), +738. 2% 10Y return). Spire Global, Inc. (SPIR) carries a higher beta of 3. 10 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ENSG: +738. 2%, SPIR: -75. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SRTA and SPIR and ASTS and ENSG and GSAT?
These companies operate in different sectors (SRTA (Industrials) and SPIR (Industrials) and ASTS (Technology) and ENSG (Healthcare) and GSAT (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SRTA is a small-cap deep-value stock; SPIR is a large-cap deep-value stock; ASTS is a mid-cap high-growth stock; ENSG is a mid-cap high-growth stock; GSAT is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 8%
- Gross Margin > 24%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.